Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Hanai

Showing results (31-40 of 68) with videos related to

Pageof 7
Sort By:
Acta Paediatrica Japonica : Overseas Edition|April 1, 1989
Mother's attitudes towards the mass screening of neuroblastomaM Nishi, H Miyake, N Takasugi, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy|October 1, 1993
[Relationship between tissue concentrations of 5-FU and degeneration of tissues after UFT administration in patients with bladder tumor]M Takeyama, M Honjoh, N Ohnishi, et al.
Oncology|January 1, 1991
Can a patient with neuroblastoma be diagnosed by a single urine sample collected randomly?M Nishi, H Miyake, T Takeda, et al.
Oncology Reports|October 14, 1998
Mass screening for neuroblastoma by HPLC and by non-HPLC: a reviewM Nishi, H Miyake, J Hanai, et al.
Japanese Journal of Clinical Oncology|December 1, 1986
Vanillylmandelic acid, homovanillic acid, and catecholamines in urine of infants with neuroblastoma 6- to 11-month-oldM Nishi, H Miyake, T Takeda, et al.
International Journal of Cancer|March 29, 2001
Lymphoproliferative disorders in renal transplant patients in JapanY Hoshida, T Li, Z Dong, et al.
Medical and Pediatric Oncology|January 1, 1989
Japanese experience of screeningT Takeda, Y Hatae, H Nakadate, et al.
Journal of Experimental & Clinical Cancer Research : CR|April 1, 2004
Is the mass screening for neuroblastoma ineffective?M Nishi, J Hanai, K Fujita, et al.
Japanese Journal of Clinical Oncology|October 1, 1994
A trial to discriminate spontaneous regression from non-regression cases during mass screening for neuroblastomaM Nishi, H Miyake, T Takeda, et al.
Histology and Histopathology|October 1, 1991
Argyrophilia in ovarian serous tumors. A comparative study in 127 epithelial ovarian tumorsM Lin, J Hanai, A Wada, et al.
Pageof 7

Showing results (31-40 of 68) with videos related to

Sort By:
Pageof 7
Acta Paediatrica Japonica : Overseas Edition|April 1, 1989
Mother's attitudes towards the mass screening of neuroblastomaM Nishi, H Miyake, N Takasugi, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy|October 1, 1993
[Relationship between tissue concentrations of 5-FU and degeneration of tissues after UFT administration in patients with bladder tumor]M Takeyama, M Honjoh, N Ohnishi, et al.
Oncology|January 1, 1991
Can a patient with neuroblastoma be diagnosed by a single urine sample collected randomly?M Nishi, H Miyake, T Takeda, et al.
Oncology Reports|October 14, 1998
Mass screening for neuroblastoma by HPLC and by non-HPLC: a reviewM Nishi, H Miyake, J Hanai, et al.
Japanese Journal of Clinical Oncology|December 1, 1986
Vanillylmandelic acid, homovanillic acid, and catecholamines in urine of infants with neuroblastoma 6- to 11-month-oldM Nishi, H Miyake, T Takeda, et al.
International Journal of Cancer|March 29, 2001
Lymphoproliferative disorders in renal transplant patients in JapanY Hoshida, T Li, Z Dong, et al.
Medical and Pediatric Oncology|January 1, 1989
Japanese experience of screeningT Takeda, Y Hatae, H Nakadate, et al.
Journal of Experimental & Clinical Cancer Research : CR|April 1, 2004
Is the mass screening for neuroblastoma ineffective?M Nishi, J Hanai, K Fujita, et al.
Japanese Journal of Clinical Oncology|October 1, 1994
A trial to discriminate spontaneous regression from non-regression cases during mass screening for neuroblastomaM Nishi, H Miyake, T Takeda, et al.
Histology and Histopathology|October 1, 1991
Argyrophilia in ovarian serous tumors. A comparative study in 127 epithelial ovarian tumorsM Lin, J Hanai, A Wada, et al.
Pageof 7